{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:31:34Z","timestamp":1726295494536},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,13]]},"DOI":"10.7759\/cureus.41820","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:54:44Z","timestamp":1689263684000},"source":"Crossref","is-referenced-by-count":1,"title":["Prostatic Abscesses in a Patient Receiving Tumor Necrosis Factor-Alpha Inhibitor Therapy for Hidradenitis Suppurativa: A Case Report"],"prefix":"10.7759","author":[{"given":"Severin","family":"Lautenschlager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e4to","family":"Strebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khosrow","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Birzele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nowag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Bieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1024\/1661-8157\/a003693","article-title":"[CME Dermatology 23: hidradenitis suppurativa]","volume":"110","author":"Dahmen RA","year":"2021","unstructured":"Dahmen RA, Lautenschlager S. [CME Dermatology 23: hidradenitis suppurativa]. Praxis (Bern 1994). 2021, 110:363-72. 10.1024\/1661-8157\/a003693","journal-title":"Praxis (Bern 1994)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball AB","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA, et al.. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016, 375:422-34. 10.1056\/NEJMoa1504370","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec GB","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012, 366:158-64. 10.1056\/NEJMcp1014163","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15097","article-title":"Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease","volume":"49","author":"Shivaji UN","year":"2019","unstructured":"Shivaji UN, Sharratt CL, Thomas T, et al.. Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2019, 49:664-80. 10.1111\/apt.15097","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5152\/tud.2020.19273","article-title":"Prostatic abscess: a systematic review of current diagnostic methods, treatment modalities and outcomes","volume":"46","author":"Khudhur H","year":"2020","unstructured":"Khudhur H, Brunckhorst O, Muir G, Jalil R, Khan A, Ahmed K. Prostatic abscess: a systematic review of current diagnostic methods, treatment modalities and outcomes. Turk J Urol. 2020, 46:262-73. 10.5152\/tud.2020.19273","journal-title":"Turk J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2018.50.1.67","article-title":"Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections","volume":"50","author":"Kang CI","year":"2018","unstructured":"Kang CI, Kim J, Park DW, et al.. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018, 50:67-100. 10.3947\/ic.2018.50.1.67","journal-title":"Infect Chemother"},{"key":"ref7","article-title":"EAU Pocket Guidelines. Edn. Presented at the EAU Annual Congress Milan 2023","author":"European Association of Urology","year":"2023","unstructured":"European Association of Urology. EAU Pocket Guidelines. Edn. Presented at the EAU Annual Congress Milan 2023. European Association of Urology, Italy; 2023."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13451","article-title":"Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era","volume":"25","author":"Ackerman AL","year":"2018","unstructured":"Ackerman AL, Parameshwar PS, Anger JT. Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era. Int J Urol. 2018, 25:103-10. 10.1111\/iju.13451","journal-title":"Int J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh JA","year":"2015","unstructured":"Singh JA, Cameron C, Noorbaloochi S, et al.. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015, 386:258-65. 10.1016\/S0140-6736(14)61704-9","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6433","article-title":"The incidence and risk of respiratory tract infections in patients using biologics for hidradenitis suppurativa: a systematic review and meta-analysis","volume":"21","author":"Mehta M","year":"2022","unstructured":"Mehta M, Hanna N, Lowes M, Alavi A. The incidence and risk of respiratory tract infections in patients using biologics for hidradenitis suppurativa: a systematic review and meta-analysis. J Drugs Dermatol. 2022, 21:819-24. 10.36849\/JDD.6433","journal-title":"J Drugs Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4236\/ojneph.2023.131002","article-title":"Prostatic abscess due to idiopathic granulomatous disease: a rare complication of a chameleon disorder","volume":"13","author":"El-Reshaid K","year":"2023","unstructured":"El-Reshaid K, Allam A, Sayed M. Prostatic abscess due to idiopathic granulomatous disease: a rare complication of a chameleon disorder. Open J Nephrol. 2023, 13:6-12. 10.4236\/ojneph.2023.131002","journal-title":"Open J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018954","article-title":"Brain abscess in a patient with psoriatic arthritis treated with adalimumab: a case report","volume":"99","author":"Lo YP","year":"2020","unstructured":"Lo YP, Desale S, Wu PY. Brain abscess in a patient with psoriatic arthritis treated with adalimumab: a case report. Medicine (Baltimore). 2020, 99:e18954. 10.1097\/MD.0000000000018954","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-022-03203-0","article-title":"Adalimumab (Humira\u00ae) induced recurrent peritonsillar abscess in a patient received three different anti-TNF therapies: a case report","volume":"75","author":"Vural S","year":"2023","unstructured":"Vural S, Ku\u015fdo\u011fan M, Kaya HB, \u0130kiz V, Albayrak L. Adalimumab (Humira\u00ae) induced recurrent peritonsillar abscess in a patient received three different anti-TNF therapies: a case report. Indian J Otolaryngol Head Neck Surg. 2023, 75:1013-5. 10.1007\/s12070-022-03203-0","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000503605","article-title":"A comparison of international management guidelines for hidradenitis suppurativa","volume":"237","author":"Hendricks AJ","year":"2021","unstructured":"Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology. 2021, 237:81-96. 10.1159\/000503605","journal-title":"Dermatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211055920","article-title":"New perspectives on the treatment of hidradenitis suppurativa","volume":"12","author":"Amat-Samaranch V","year":"2021","unstructured":"Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021, 12:20406223211055920. 10.1177\/20406223211055920","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/166968-prostatic-abscesses-in-a-patient-receiving-tumor-necrosis-factor-alpha-inhibitor-therapy-for-hidradenitis-suppurativa-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:43Z","timestamp":1707509083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/166968-prostatic-abscesses-in-a-patient-receiving-tumor-necrosis-factor-alpha-inhibitor-therapy-for-hidradenitis-suppurativa-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.41820","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}